Trials / Completed
CompletedNCT00092105
Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)
A Multicenter, Double-Blind, Randomized, Crossover Study Investigating the Clinical Effect of Montelukast in Patients With Concomitant Asthma and Allergic Rhinitis Upon Controlled Exposure to Cat Allergen
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 15 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the protective effect of an approved medication on asthma and allergic rhinitis (inflammation of the mucous membrane of the nose) upon exposure to cats.
Detailed description
The duration of treatment is 2 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0476, montelukast sodium | |
| DRUG | Comparator: placebo |
Timeline
- Start date
- 2002-04-01
- Primary completion
- 2003-01-01
- Completion
- 2003-01-28
- First posted
- 2004-09-24
- Last updated
- 2024-08-14
Source: ClinicalTrials.gov record NCT00092105. Inclusion in this directory is not an endorsement.